Pharmala Biotech Holdings Inc.
MDXXF
$0.07
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.73% | -60.74% | -22.99% | -241.88% | -1,404.49% |
| Total Depreciation and Amortization | -54.42% | 131.79% | -19.83% | -22.22% | 85.34% |
| Total Amortization of Deferred Charges | -- | -75.05% | -- | -- | -- |
| Total Other Non-Cash Items | -43.91% | -121.10% | -48.04% | 1,368.65% | 94.88% |
| Change in Net Operating Assets | 320.11% | 168.89% | 120.29% | -49.95% | 70.28% |
| Cash from Operations | 52.10% | -7,313.79% | -10.65% | -122.82% | -1,754.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 742.13% | 552.94% | 348.28% | -1,434.34% | 57.00% |
| Cash from Investing | 742.13% | 546.76% | 348.28% | -1,434.34% | 57.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -39.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -- | 88.36% | -100.00% | -- | -39.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.31% | -17.20% | -128.85% | 134.39% | -886.76% |